Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman.

Ainsworth AJ, Dashti NK, Mounajjed T, Fritchie KJ, Davila J, Mopuri R, Jackson RA, Halling KC, Bakkum-Gamez JN, Schoolmeester JK.

Diagn Pathol. 2019 Apr 25;14(1):32. doi: 10.1186/s13000-019-0809-1.

2.

RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cyst.

Blackburn PR, Davila JI, Jackson RA, Fadra N, Atiq MA, Pitel BA, Nair AA, VanDeWalker TJ, Hessler MG, Hovel SK, Wehrs RN, Fritchie KJ, Jenkins RB, Halling KC, Geiersbach KB.

Genes Chromosomes Cancer. 2019 Aug;58(8):589-594. doi: 10.1002/gcc.22742. Epub 2019 Mar 6.

PMID:
30767316
3.

A Case of Donor-Transmitted Non-Small Cell Lung Cancer After Liver Transplantation: An Unwelcome Guest.

Sonbol MB, Halling KC, Douglas DD, Ross HJ.

Oncologist. 2019 Jun;24(6):e391-e393. doi: 10.1634/theoncologist.2018-0517. Epub 2019 Feb 12.

PMID:
30755501
4.

Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy.

Blessing MM, Blackburn PR, Balcom JR, Krishnan C, Harrod VL, Zimmermann MT, Barr Fritcher EG, Zysk CD, Jackson RA, Nair AA, Jenkins RB, Halling KC, Kipp BR, Ida CM.

Acta Neuropathol Commun. 2018 Nov 5;6(1):118. doi: 10.1186/s40478-018-0622-1. No abstract available.

5.

Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing.

Milosevic D, Mills JR, Campion MB, Vidal-Folch N, Voss JS, Halling KC, Highsmith WE, Liu MC, Kipp BR, Grebe SKG.

Clin Chem. 2018 Dec;64(12):1732-1742. doi: 10.1373/clinchem.2018.291278. Epub 2018 Sep 20.

PMID:
30237149
6.

Multiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target.

Mangaonkar AA, Patnaik MM, Oliver GR, Rao KW, Kaiser-Rogers K, Davila JI, Fadra N, Wehrs RN, Elliott MA, Greipp PT, Halling KC, Van Dyke DL.

Leuk Lymphoma. 2019 Mar;60(3):821-824. doi: 10.1080/10428194.2018.1498492. Epub 2018 Aug 30. No abstract available.

PMID:
30160574
7.

Patients' experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study.

Degboe A, Knight SL, Halling K, Trigg A, Al-Zubeidi T, Aldhouse N, Kitchen H, Wirth L, Rogers SN.

J Patient Rep Outcomes. 2018 Aug 1;2:33. doi: 10.1186/s41687-018-0060-7. eCollection 2017.

8.

Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumors.

Winters JL, Davila JI, McDonald AM, Nair AA, Fadra N, Wehrs RN, Thomas BC, Balcom JR, Jin L, Wu X, Voss JS, Klee EW, Oliver GR, Graham RP, Neff JL, Rumilla KM, Aypar U, Kipp BR, Jenkins RB, Jen J, Halling KC.

J Mol Diagn. 2018 Jul;20(4):495-511. doi: 10.1016/j.jmoldx.2018.03.007. Epub 2018 Jun 19.

9.

Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.

Dashti NK, Wehrs RN, Thomas BC, Nair A, Davila J, Buckner JC, Martinez AP, Sukov WR, Halling KC, Howe BM, Folpe AL.

Histopathology. 2018 Sep;73(3):514-520. doi: 10.1111/his.13649. Epub 2018 Jun 29.

PMID:
29758589
10.

Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients.

Gelhorn HL, Skalicky AM, Balantac Z, Eremenco S, Cimms T, Halling K, Hollen PJ, Gralla RJ, Mahoney MC, Sexton C.

Support Care Cancer. 2018 Jul;26(7):2229-2238. doi: 10.1007/s00520-018-4061-0. Epub 2018 Feb 1.

PMID:
29392480
11.

Contraction of T cell richness in lung cancer brain metastases.

Mansfield AS, Ren H, Sutor S, Sarangi V, Nair A, Davila J, Elsbernd LR, Udell JB, Dronca RS, Park S, Markovic SN, Sun Z, Halling KC, Nevala WK, Aubry MC, Dong H, Jen J.

Sci Rep. 2018 Feb 1;8(1):2171. doi: 10.1038/s41598-018-20622-8.

12.

Understanding polycystic ovary syndrome from the patient perspective: a concept elicitation patient interview study.

Martin ML, Halling K, Eek D, Krohe M, Paty J.

Health Qual Life Outcomes. 2017 Aug 18;15(1):162. doi: 10.1186/s12955-017-0736-3.

13.

Patient Centricity and Pharmaceutical Companies: Is It Feasible?

du Plessis D, Sake JK, Halling K, Morgan J, Georgieva A, Bertelsen N.

Ther Innov Regul Sci. 2017 Jul;51(4):460-467. doi: 10.1177/2168479017696268. Epub 2017 Mar 28.

PMID:
30227057
14.

A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.

Poneros JM, Faye AS, Barr Fritcher EG, Sen A, Anandasabapathy S, Bresalier RS, Marcon N, Turgeon DK, Appelman H, Normolle D, Morrison LE, Brenner DE, Halling KC.

Dig Dis Sci. 2017 May;62(5):1216-1222. doi: 10.1007/s10620-017-4517-y. Epub 2017 Mar 6.

15.

Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma.

Gelhorn HL, Eremenco S, Skalicky AM, Balantac Z, Cimms T, Halling K, Sexton C.

J Patient Rep Outcomes. 2017;2(1):16. doi: 10.1186/s41687-018-0039-4. Epub 2018 Mar 27.

16.

Impact of RNA degradation on fusion detection by RNA-seq.

Davila JI, Fadra NM, Wang X, McDonald AM, Nair AA, Crusan BR, Wu X, Blommel JH, Jen J, Rumilla KM, Jenkins RB, Aypar U, Klee EW, Kipp BR, Halling KC.

BMC Genomics. 2016 Oct 20;17(1):814.

17.

Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy.

Rydén A, Leavy OC, Halling K, Stone AA.

Value Health. 2016 Sep - Oct;19(6):829-833. doi: 10.1016/j.jval.2016.05.007. Epub 2016 Jun 29.

18.

What Do Ovarian Cancer Patients Expect From Treatment?: Perspectives From an Online Patient Community.

Simacek K, Raja P, Chiauzzi E, Eek D, Halling K.

Cancer Nurs. 2017 Sep/Oct;40(5):E17-E27. doi: 10.1097/NCC.0000000000000415.

PMID:
27454765
19.

Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model.

Borghs S, Tomaszewski EL, Halling K, de la Loge C.

Patient. 2016 Oct;9(5):419-31. doi: 10.1007/s40271-016-0165-0.

PMID:
27002318
20.

Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients.

Chaiteerakij R, Barr Fritcher EG, Angsuwatcharakon P, Ridtitid W, Chaithongrat S, Leerapun A, Baron TH, Kipp BR, Henry MR, Halling KC, Rerknimitr R, Roberts LR.

Gastrointest Endosc. 2016 Jun;83(6):1228-35. doi: 10.1016/j.gie.2015.11.037. Epub 2015 Dec 10.

PMID:
26684604
21.

Defensive Perimeter in the Central Nervous System: Predominance of Astrocytes and Astrogliosis during Recovery from Varicella-Zoster Virus Encephalitis.

Carpenter JE, Clayton AC, Halling KC, Bonthius DJ, Buckingham EM, Jackson W, Dotzler SM, Card JP, Enquist LW, Grose C.

J Virol. 2015 Oct 21;90(1):379-91. doi: 10.1128/JVI.02389-15. Print 2016 Jan 1.

22.

An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.

Barr Fritcher EG, Voss JS, Brankley SM, Campion MB, Jenkins SM, Keeney ME, Henry MR, Kerr SM, Chaiteerakij R, Pestova EV, Clayton AC, Zhang J, Roberts LR, Gores GJ, Halling KC, Kipp BR.

Gastroenterology. 2015 Dec;149(7):1813-1824.e1. doi: 10.1053/j.gastro.2015.08.046. Epub 2015 Aug 29.

PMID:
26327129
23.

SERPINA1 Full-Gene Sequencing Identifies Rare Mutations Not Detected in Targeted Mutation Analysis.

Graham RP, Dina MA, Howe SC, Butz ML, Willkomm KS, Murray DL, Snyder MR, Rumilla KM, Halling KC, Highsmith WE Jr.

J Mol Diagn. 2015 Nov;17(6):689-94. doi: 10.1016/j.jmoldx.2015.07.002. Epub 2015 Aug 28.

PMID:
26321041
24.

Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas.

Graham RP, Kerr SE, Butz ML, Thibodeau SN, Halling KC, Smyrk TC, Dina MA, Waugh VM, Rumilla KM.

Am J Surg Pathol. 2015 Oct;39(10):1370-6. doi: 10.1097/PAS.0000000000000459.

PMID:
26099011
25.

Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma.

Yang JD, Campion MB, Liu MC, Chaiteerakij R, Giama NH, Ahmed Mohammed H, Zhang X, Hu C, Campion VL, Jen J, Venkatesh SK, Halling KC, Kipp BR, Roberts LR.

Hepatology. 2016 Jan;63(1):148-58. doi: 10.1002/hep.27944. Epub 2015 Aug 7.

26.

Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.

Brankley SM, Halling KC, Jenkins SM, Timmer MR, Iyer PG, Smyrk TC, Barr Fritcher EG, Voss JS, Kipp BR, Campion MB, Lutzke LS, Minot DM, Wang KK.

Dis Esophagus. 2016 Aug;29(6):513-9. doi: 10.1111/dote.12372. Epub 2015 Jun 5.

27.

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.

Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A, Senz J, Yang W, Prigge ES, Reuschenbach M, Doeberitz MV, Gilks BC, Huntsman DG, Bakkum-Gamez J, McAlpine JN, Anglesio MS.

BMC Cancer. 2015 May 19;15:415. doi: 10.1186/s12885-015-1421-8.

28.

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

Graham RP, Jin L, Knutson DL, Kloft-Nelson SM, Greipp PT, Waldburger N, Roessler S, Longerich T, Roberts LR, Oliveira AM, Halling KC, Schirmacher P, Torbenson MS.

Mod Pathol. 2015 Jun;28(6):822-9. doi: 10.1038/modpathol.2015.4. Epub 2015 Feb 20.

29.

Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.

Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, Famuyide AO, Clayton AC, Halling KC, Kerr SE, Cliby WA, Dowdy SC, Kipp BR, Mariani A, Oberg AL, Podratz KC, Shridhar V, Sherman ME.

Gynecol Oncol. 2015 Apr;137(1):14-22. doi: 10.1016/j.ygyno.2015.01.552. Epub 2015 Feb 10.

30.

Detection of circulating tumor cells in high-risk endometrial cancer.

Bogani G, Liu MC, Dowdy SC, Cliby WA, Kerr SE, Kalli KR, Kipp BR, Halling KC, Campion MB, Mariani A.

Anticancer Res. 2015 Feb;35(2):683-7.

PMID:
25667446
31.

Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.

Eaton JE, Barr Fritcher EG, Gores GJ, Atkinson EJ, Tabibian JH, Topazian MD, Gossard AA, Halling KC, Kipp BR, Lazaridis KN.

Am J Gastroenterol. 2015 Feb;110(2):299-309. doi: 10.1038/ajg.2014.433. Epub 2015 Jan 27.

32.

Diagnostic accuracy of bronchial brush cytology and the added value of immunohistochemistry and fluorescence in situ hybridization of pulmonary neuroendocrine tumors.

Reynolds JP, Voss JS, Brankley SM, Caudill JM, Henry MR, Clayton AC, Halling KC, Nassar A.

Cytojournal. 2014 Dec 3;11:32. doi: 10.4103/1742-6413.146120. eCollection 2014.

33.

Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.

Timmer MR, Brankley SM, Gorospe EC, Sun G, Lutzke LS, Iyer PG, Halling KC, Krishnadath KK, Wang KK.

Gastrointest Endosc. 2014 Dec;80(6):984-91. doi: 10.1016/j.gie.2014.06.023. Epub 2014 Jul 29.

34.

FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.

Barr Fritcher EG, Kipp BR, Halling KC, Clayton AC.

Cytopathology. 2014 Oct;25(5):288-301. doi: 10.1111/cyt.12170. Epub 2014 Jul 30. Review.

PMID:
25073411
35.

Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.

Kerr SE, Barr Fritcher EG, Campion MB, Voss JS, Kipp BR, Halling KC, Lewis JT.

Hum Pathol. 2014 Sep;45(9):1797-804. doi: 10.1016/j.humpath.2014.05.008. Epub 2014 Jun 4.

PMID:
25027853
36.

Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.

Graham RP, Barr Fritcher EG, Pestova E, Schulz J, Sitailo LA, Vasmatzis G, Murphy SJ, McWilliams RR, Hart SN, Halling KC, Roberts LR, Gores GJ, Couch FJ, Zhang L, Borad MJ, Kipp BR.

Hum Pathol. 2014 Aug;45(8):1630-8. doi: 10.1016/j.humpath.2014.03.014. Epub 2014 Apr 13.

PMID:
24837095
37.

Development and validation of the AFSymp™: an atrial fibrillation-specific measure of patient-reported symptoms.

Medin J, Arbuckle R, Abetz L, Halling K, Kulich K, Edvardsson N, Coyne KS.

Patient. 2014;7(3):319-27. doi: 10.1007/s40271-014-0058-z.

PMID:
24733480
38.

Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples.

Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J, Halling KC.

Cancer Cytopathol. 2014 Jun;122(6):459-67. doi: 10.1002/cncy.21414. Epub 2014 Mar 6.

39.

Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012.

Boyle TA, Bridge JA, Sabatini LM, Nowak JA, Vasalos P, Jennings LJ, Halling KC; College of American Pathologists Molecular Oncology Committee.

Arch Pathol Lab Med. 2014 Mar;138(3):363-70. doi: 10.5858/arpa.2013-0159-CP.

PMID:
24576032
40.

A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells.

Viray H, Li K, Long TA, Vasalos P, Bridge JA, Jennings LJ, Halling KC, Hameed M, Rimm DL.

Arch Pathol Lab Med. 2013 Nov;137(11):1545-9. doi: 10.5858/arpa.2012-0561-CP.

PMID:
24168492
41.

Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.

Voss JS, Iqbal S, Jenkins SM, Henry MR, Clayton AC, Jett JR, Kipp BR, Halling KC, Maldonado F.

Hum Pathol. 2014 Jan;45(1):41-7. doi: 10.1016/j.humpath.2013.07.038. Epub 2013 Oct 16.

PMID:
24139213
42.
43.

Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

Barr Fritcher EG, Voss JS, Jenkins SM, Lingineni RK, Clayton AC, Roberts LR, Halling KC, Talwalkar JA, Gores GJ, Kipp BR.

Cancer Cytopathol. 2013 Dec;121(12):708-17. doi: 10.1002/cncy.21331. Epub 2013 Jul 9.

44.

Matching maternal isodisomy in mucinous carcinomas and associated ovarian teratomas provides evidence of germ cell derivation for some mucinous ovarian tumors.

Kerr SE, Flotte AB, McFalls MJ, Vrana JA, Halling KC, Bell DA.

Am J Surg Pathol. 2013 Aug;37(8):1229-35. doi: 10.1097/PAS.0b013e31828f9ecb.

PMID:
23774174
45.

BRAF mutation-positive folliculotropic metastatic melanoma.

Brick KE, Halling KC, Khan YK, Peters MS.

Am J Dermatopathol. 2013 Jul;35(5):609-12. doi: 10.1097/DAD.0b013e31827a0bfb.

PMID:
23715079
46.

Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.

Kipp BR, Barr Fritcher EG, Pettengill JE, Halling KC, Clayton AC.

Cancer Cytopathol. 2013 Nov;121(11):610-9. doi: 10.1002/cncy.21303. Epub 2013 Apr 30. Review.

47.

Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification.

Vakil N, Halling K, Ohlsson L, Wernersson B.

Am J Gastroenterol. 2013 May;108(5):767-74. doi: 10.1038/ajg.2013.89. Epub 2013 Apr 9.

PMID:
23567354
48.

Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.

Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR.

Hum Pathol. 2013 Jul;44(7):1216-22. doi: 10.1016/j.humpath.2012.11.006. Epub 2013 Feb 4.

PMID:
23391413
49.

Interlaboratory comparison of IDH mutation detection.

van den Bent MJ, Hartmann C, Preusser M, Ströbel T, Dubbink HJ, Kros JM, von Deimling A, Boisselier B, Sanson M, Halling KC, Diefes KL, Aldape K, Giannini C.

J Neurooncol. 2013 Apr;112(2):173-8. doi: 10.1007/s11060-013-1056-z. Epub 2013 Jan 29.

PMID:
23358936
50.

Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy.

Vakil N, Björck K, Denison H, Halling K, Karlsson M, Paty J, Silberg DG, Rydén A.

Clin Transl Gastroenterol. 2012 Jan 26;3:e7. doi: 10.1038/ctg.2012.1.

Supplemental Content

Loading ...
Support Center